Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer

Autor:	R. Charles Coombes, Selina Raguz, Yunhui Hu, John Gallon, Poonam Singh, Sami Shousha, Meng-Lay Lin, Muhammad Asaduzzaman, Ernesto Yagüe, Stephanie Constantinou, Simak Ali, Eric Lam, Haoxiang Min
Přispěvatelé:	Breast Cancer Research Trust
Rok vydání:	2018
Předmět:	Cancer Research Science & Technology business.industry Paclitaxel resistance medicine.disease law.invention Blot Breast cancer Text mining Oncology law Cancer research medicine Suppressor Oncology & Carcinogenesis business EP300 Life Sciences & Biomedicine 1112 Oncology And Carcinogenesis
Zdroj:	Breast Cancer Research and Treatment. 167:605-606
ISSN:	1573-7217 0167-6806
DOI:	10.1007/s10549-017-4633-6
Popis:	In the original publication, Fig. 1 depicting the blot for EP300 in CAL51 cells (Fig. 1c) was unintentionally duplicated with that from MDA-MB-231 cells (Fig. 1d). The new figure given in this erratum depicts the correct EP300 blot in Fig. 1c.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac3ec46a9172f1c8d799da8a5be4f368 https://doi.org/10.1007/s10549-017-4633-6 Zobrazit plný text záznamu Full text from SpringerLink